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Abstract 
 
The effect of the protonation state of the hydroxyl-ethylthiamin diphosphate intermediate, 
HEThDP, on the enzyme-substrate interactions and their consequences on the biosynthesis 
of R-phenylacetylcarbinol, R-PAC, by the acetohydroxy acid synthase, AHAS, is addressed 
by molecular dynamics simulations. It is found that the form of HEThDP, which favors the 
formation of R-PAC, is that having the 4-aminopyrimidine ring with the N1´ atom 
protonated and the N4´ atom as aminopyrimidium ion. Under this form both active sites of 
AHAS have the ability to perform the catalysis, unlike that observed for the other possible 
protonation states of N1´and N4´ atoms.  
                                                         * E-mail: edelgado@udec.cl 
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Introduction 
R-phenylacetylcarbinol, R-PAC, is an important precursor in the production of a wide 
variety of drugs with β-adrenergic agonist/antagonist properties. Production of R-PAC 
using the yeast Saccharomyces cerevisiae, glucose and benzaldehyde was the first chiral 
biotransformation process commercialized [1,2]. In this fermentative route, R-PAC is 
formed due to the condensation of pyruvate and benzaldehyde catalyzed by the enzyme 
pyruvate decarboxylase (PDC). The process has low efficiency, substrate toxicity toward 
living cells and production of important amounts of by-products due to the action of 
multiple intracellular enzymes. In recent years important efforts have been devoted to the 
development of processes based on purified catalysts rather than whole cell fermentation 
[3,4]. It has been found that in addition to catalyze the physiological reactions leading to 
the formation of (2s)-2-acetohydroxybutyrate and (2S)-2-acetolactate synthase, 
acetohydroxy acid synthase, AHAS, can catalyze the formation of R-PAC, from the 
reaction between the intermediate hydroxyl-ethylthiamin diphosphate HEThDP and 
benzaldehyde (BA), with an enantiomeric specificity over 98 %. Despite knowing the stage 
of the catalytic cycle in which the non-physiological acceptor substrate benzaldehyde 
participates, the identification of the protonation state of the 4-aminopyrimidine ring and its 
consequences on the biosynthesis of R-PAC, has not been clarified so far. This is due to the 
fact that the R-PAC, formed in steps 3 and 4 of the catalytic cycle of the AHAS competes 
directly with the formation of the natural product of the enzyme. In a recent article [5], we 
used a clusterized model to assess the role of the protonation state of the N1´and N4´ atoms 
of the 4-aminopyrimidine ring of the HEThDP intermediate on the activation barrier. It was 
observed that the lowest activation barrier is obtained when the residue Glu139 is 
protonated, i.e. as glutamic acid, and the atom N1´ of 4’-aminopyrimidine ring 
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deprotonated. The next one in the series corresponds to that having the Glu139 as glutamate 
and the atom N1´ of 4´-aminopyrimidium ring protonated. Finally, the highest activation 
barrier corresponded to the tautomer having the Glu139 as glutamate and the atom N1´atom 
protonated and the N4´atom aminopyrimidium.  
The present work addresses the important question of the interplay of the protein 
environment and the protonation state of the HEThDP intermediate as a determining factor 
for the enzymatic biosynthesis of R-PAC. Thus, by means of molecular dynamics 
simulations we studied the effect of the different possible protonation states of the 
HEThDP-BA complex on the interactions with the active site residues. Our results indicate 
that the intermediate HEThDP should be with the N1´ atom protonated and the N4´atom as 
aminopyrimidium, in order to enhance the biosynthesis of R-PAC, in comparison to the 
physiological products. 
 
Methodology 
i) Modeling of the enzyme-substrate complex 
The crystal structure of AHAS from Saccharomyces cerevisiae yeast in complex with the 
herbicide chlorimuron ethyl, determined at 2.8 Å (PDB code 1N0H), was used as the 
starting structure. This structure is composed by two monomers, called A y B from now on. 
They are composed by 599 and 598 amino acids, respectively. The crystal structure shows 
two active sites, two molecules of FAD, two atoms of Mg2+, in addition to two molecules 
of herbicides and 832 crystallization water molecules. The thiazolium and pyrimidine rings 
that make up the thiamin diphosphate cofactor, ThDP, are joined by a bridge carbon 
forming the dihedral angles Φp = N3-C7’-C5’-C4’ and ΦT = C2-N3-C7’-C5’ as shown in 
Figure 1. When the dihedral angles Φp and ΦT adopt values close to -70° and +95°, 
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respectively, the cofactor ThDP adopt the active conformation type V, in which the 
nitrogen atom bound to the pyrimidine ring is oriented close to the carbon C2 of the 
thiazolium ring. 
The cofactor of the monomer A shows the thiazolium ring partially degraded, without the 
atoms S1 and C2. On the other hand, the cofactor of monomer B does not show loss of 
atoms in its structure. Besides, between the α and β domains of the two monomers the 
crystal structure shows the loss of the peptide sequence comprising the residues between 
Asn271 and Leu276 for the monomer A, and Asn271 and Thr277 for the monomer B [6].  
 
Figure 1. Definition of dihedral angles Φp and ΦT of ThDP. 
To rebuild the crystal structure, and to complete the amino acid sequence, the GaussView 
5.0.8 [7] and VMD 1.9.2 [8] softwares were used. Briefly, the HEThDP intermediate was 
positioned by superimposing its ThDP moiety with the ThDP cofactor originally located in 
such active site. Three possible combinations of the different protonation states of the N1´ 
and N4´atoms of the HEThDP intermediate were considered, namely, forms AP, APH+ and 
IP, as shown in Figure 2. 
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Figure 2. Tautomeric/ionic forms of the HEThDP intermediate: (A) Form AP, (B) Form 
APH+, (C) Form IP. 
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The enzyme-HEThDP-BA complexes were build considering the forms AP, APH+ and IP 
of the HEThDP intermediate, generating three complexes labeled, from now on, as CPX-1, 
CPX-2 and CPX-3, respectively. The protonation states of all ionizable residues were set to 
the states corresponding to pH 7.0 by using PROPKA 3.0 [9,10]. The enzyme-HEThDP-
BA complexes were solvated using a cubic box of water molecules (112 x 102 x 123 Å3) 
centered in the geometric center of the system. These dimensions of the box ensure that all 
protein atoms are at least 10 Å away from the edges of the box. The final system for the 
CPX-1 complex consists of 136384 atoms, of which 18516 are protein atoms, 117564 are 
water atoms, 6 are sodium ions, 2 are chloride ions, 2 are magnesium ions, 2 are potassium 
ions incorporated in the crystal structure, and 84 atoms from the FAD cofactor. While, the 
system for the CPX-2 complex contains 136392 atoms, of which 18514 correspond to 
protein atoms, 117576 are water atoms, 4 are sodium ions, 2 are magnesium ions, 2 are 
potassium ions, and 84 atoms from the FAD cofactor. Finally, for CPX-3 the system 
consists of 136372 atoms, of which 18514 are protein atoms 117552 are water atoms, 8 are 
sodium ions, 2 are chloride ions, 2 are magnesium ions, 2 are potassium ions, and 84 atoms 
from the FAD cofactor. For all calculations, protein atoms were described using 
CHARM36 [11,12], while water molecules were described using TIP3P potentials [13].  
 
ii) Molecular dynamics simulations 
Molecular Dynamics (MD) simulations were carried out using the NAMD program [14]. 
Periodic boundary conditions were imposed and the isothermal-isobaric ensemble (NPT) 
was used. The temperature (300 K) and pressure (1 atm.) were maintained using NAMD 
Nosé-Hoover implementations [15,16]. Electrostatic interactions were calculated directly 
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within a cutoff of 12 Å, whereas long-range electrostatics effects were taken into account 
by the Particle Mesh Ewald summation method [17]. Van der Waals interactions were 
treated using a switch function starting at 10 Å and turning off at 12 Å.  The parameters and 
topology files for FAD and the HEThDP-BA complex were obtained using the CGenFF 
program of CHARMM, [18-20] while the atomic charges were obtained by means of single 
point calculations of the cofactors employing GAUSSIAN 09 [21] and the CHELPG 
population analysis. 
To remove close contacts and the highly repulsive orientation of the initial protein-solvent 
system, 100000 steps of energy minimization of the water molecules were carried out using 
the algorithm of conjugated gradients. Afterwards, a new minimization of 100000 steps was 
carried out for the protein structure of the enzyme to finish with a full minimization of 
100000 steps for the total enzyme-solvent system. From the resulting configuration, 100 ps 
of MD simulations were performed with a time step of 1 fs from 50 K to 400K, with step of 
50 K; followed by the system cooling at 300K to equilibrate the system up to the working 
temperature. Additionally, an equilibrium MD simulation of 1 ns was performed at 300K. 
This procedure was carried out with the purpose of restoring the positions of the side chains 
of the residues of the active sites of the systems under study, due to the change made by 
eliminating the herbicide molecules and the reconstruction of the ThDP cofactor to the 
complex form. CPX-1, CPX-2 and CPX-3. The temperature changes were made gradually, 
without breaking the equilibrium of the systems, maintaining the conformations of the 
secondary and tertiary structures of the systems in addition to important non-binding 
interactions such as Glu139, Met525 and Gly523. This was done, with the purpose of 
obtaining initial structures for the DM-MM simulations in which the residues of the active 
sites were in positions according to the reconstructed complexes. This methodology has 
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been carried out previously in simulations of molecular dynamics for systems with 
reconstruction and changes in the molecular structure of the simulated cofactors in order to 
escape from the local minimum in which the original crystalline structures are 
found.[22,23] Finally, production simulations of 100 ns with a 2 fs time step were carried 
out. During these simulations, all intramolecular motions involving hydrogen atoms were 
frozen by using the SHAKE algorithm [24,25]. Analysis of the trajectories was carried out 
with VMD. 
 
Results and Discussion 
 
The obtained plot of root-mean-square-deviation (RMSD) for the complete system of both 
active sites (Figure S1 in Supporting Information) shows that the CPX-2 complex reaches 
the conformational stability at about 30 ns, while for the other forms a steady increasing 
value of RMSD is observed until about 70 ns, time at which the values of RMSD for the 
three complexes are similar. The stability of the secondary and tertiary structure of the 
protein is assessed by means of the number of hydrogen bonds in the enzyme. The plot of 
the number of hydrogen bonds in the enzyme for each system along the simulation (Figure 
S2 in Supporting Information) shows the hydrogens bonds between residues pairs. It is 
observed a very stable count along the simulation evidencing the stability of the secondary 
structure for the three complexes, CPX-1, CPX-2 and CPX-3. The root mean square 
fluctuation (RMSF) results for alpha carbon of key residues located in active sites 1 and 2, 
after 100 ns simulations, are compiled in the Figure 3. The values show a very stable 
behavior for the three-protonation forms of the intermediate HEThDP in both active sites 1 
and 2, the values vary between 0.4 and 1.2 (Å) and in general remain below 1.0 Å. 
 9 
It has been suggested in the literature [26,27] that the carbonyl groups of the alternative 
second substrates make similar contacts in the enzyme active sites as they react with the 
HEThDP intermediate, therefore the aromatic ring of benzaldehyde and the carboxyl group 
of a ketoacid must occupy the same general region in the site. Thus, the hydrogen on the 
new chiral carbon of R-PAC would point in the same direction as the methyl or ethyl group 
of the acetohydroxy acid [27], since it is postulated that the protonation of the carbonyl 
oxygen  involves the same proton donor in both reactions.  
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Figure 3. Root mean square fluctuation (RMSF) of key residues for both active sites along 
the 100 ns of simulation. (A) CPX-1 complex, (B) CPX-2 complex, (C) CPX-3 
complex.  
 
Mutagenesis studies [34] show that when Arg380 is replaced by methionine, phenylalanine, 
glutamine or lysine, the ability to synthesize the physiological product (2S)-2-acetolactate 
is severely affected, whereas the mutations did not affect the formation of R-PAC, therefore 
it is postulated that the Arg380 does not play a catalytic role in the formation of R-PAC. 
Based on these results, it is possible to infer that Arg380 should be located at distances far 
from the benzaldehyde and HEThDP intermediate. In Figures 4-6, we show the average 
structures for the 100 ns simulations for both active sites and for the three possible forms of 
the complexes HEThDP-BA: CPX-1, CPX-2, CPX-3.  
It is observed that only the CPX-2 complex meet the conditions mentioned above in both 
active sites. Thus, the distances from Arg380 to the benzene ring are 10.3 Å and 10.2 Å, for 
the active site 1 and active site 2, respectively, in agreement with that postulated in 
literature [27]. While for the other complexes, CPX-1 and CPX-3, this distance is much 
lower than the above figures, and also show different values for the active sites 1 and 2, in 
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the same complex. Moreover, it has been proposed [27] that Gly116 would interact by 
means of hydrogen bonding with the carbonyl oxygen of benzaldehyde, stabilizing the 
charge density on the oxygen atom and increasing in this way the electrophilicity of the 
carbonyl carbon. This distance for CPX-2 is 3.17 Å and 2.20 Å for active sites 1 and 2, 
respectively, compared to the values (4.50 Å, 6.52 Å) and (7.65 Å, 4.73 Å) for the 
complexes CPX-1 and CPX-3, respectively. On the other hand, Gln202 would interact by 
means hydrogen bonding with the hydroxyl oxygen of HEThDP, allowing the proton 
transfer toward the carbonyl oxygen the benzaldehyde [27,28]. The respective values, in the 
active site 1 and active site 2, are (4.94 Å, 4.71 Å), (2.10 Å, 2.13 Å) and (4.42 Å, 4.92 Å), 
for the complexes CPX-1, CPX-2 and CPX-3, respectively. All these structural values 
suggest that this interaction is more favored in the complex CPX-2, compared to complexes 
CPX-1 and CPX-3. All the above mentioned distances are showed in Figures 4-6. 
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Figure 4. (A) Average structure from the 100 ns simulation for CPX-1 form in the active site 
1; (B) Average structure from the 100 ns simulation for CPX-1 form in the active site 2. 
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Figure 5. (A) Average structure from  the 100 ns simulation for CPX-2 form in the active site 
1;(B) Average structure from the 100 ns simulation for CPX-2 form in the active site 2. 
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Figure 6. (A) Average structure from the 100 ns simulation for CPX-3 form in the active site 
1; (B) Average structure from the 100 ns simulation for CPX-3 form in the active site 2. 
 
On the other hand, it has been suggested that the Met525 play a role purely structural to 
keep the active conformation V by means of hydrogen bonding interaction with the 
nitrogen N3´ of the pyrimidine ring of HEThDP [6,29]. The distances values between these 
two centers, for the active site 1 and active site 2, are (4.06 Å, 6.56 Å), (2.51 Å, 2.37 Å) 
and (5.00 Å, 2.30 Å) for the complexes CPX-1, CPX-2 and CPX-3, respectively.  
Finally, it is necessary to stress that only the complex CPX-2 shows the geometric features 
required to maintain the interactions with key residues reported in literature. In addition, 
both active sites show similar characteristics and, in consequence, both active sites are able 
to carry out the biosynthesis of R-PAC. 
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Conclusions 
The present MD study has been carried out to determine the protonation state of the 
pyrimidine ring of the intermediate HEThDP during the biosynthesis of R-PAC by AHAS. 
Our results clearly point that the only protonation state consistent with the structural 
features reported in the literature is that in which the N1´atom is protonated and the 
N4´atom is in the form 4’-aminopyrimidium ion, complex CPX-2. In addition, only under 
this form both active sites show the same right structural features, which provide the ability 
to perform the catalysis. This condition would grant a maximum efficiency to the enzyme. 
For the other protonation states of the pyrimidine ring, mixed results are obtained; namely 
the structural features of both active sites are different each other, although one of them 
may also show a reasonable agreement with those interactions identified in literature as 
relevant for the catalysis. Thus, for the complexes CPX-1 and CPX-3, our simulations 
indicate that only one active site would be able to perform the catalysis reducing the 
efficiency of the enzyme. On the other hand, having in mind that once the product R-PAC 
is released, the enzyme must recover its initial condition to initiate the catalytic cycle once 
more, namely the cofactor ThDP in the form of ylide. The only complex among those 
considered in this study that would recover the ylide intermediary is the complex CPX-2. In 
closing, to the best of our knowledge this issue has not been addressed in literature so far, 
therefore the significance of the study lies on the novelty of the results and they would be 
of interest for those researchers involved on the development of enzymatic processes based 
on AHAS for the production of chiral building blocks for bioactive molecules. 
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